Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors, Personalized Prognoses and 1-year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19

NCT04457505 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.

NCT NCT04457505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors, Personalized Prognoses and 1-year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase
Observational
Overall status
Completed
Start date
May 8, 2020
Completion date
December 31, 2021
Enrollment
8,500 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, respiratory failure, severe pneumonia